newsfilter
← Latest News
PR Newswire·

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

Increased net product revenue more than 35% in the first quarter of 2023 vs. prior year quarter Reduced operating expenses more than 70% Decreased loss from operations more than 85% Reaffirms path to positive EDITDA SAN